Dean NM - Search Results

1

Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxynucleotide.

Yazaki T, Ahmad S, Chahlavi A, Zylber-Katz E, Dean NM, Rabkin SD, Martuza RL, Glazer RI. Yazaki T, et al. Among authors: dean nm. Mol Pharmacol. 1996 Aug;50(2):236-42. Mol Pharmacol. 1996. PMID: 8700129

2

Induction of p53-dependent, insulin-like growth factor-binding protein-3-mediated apoptosis in glioblastoma multiforme cells by a protein kinase Calpha antisense oligonucleotide.

Shen L, Dean NM, Glazer RI. Shen L, et al. Among authors: dean nm. Mol Pharmacol. 1999 Feb;55(2):396-402. doi: 10.1124/mol.55.2.396. Mol Pharmacol. 1999. PMID: 9927633

3

Use of a chemically modified antisense oligonucleotide library to identify and validate Eg5 (kinesin-like 1) as a target for antineoplastic drug development.

Koller E, Propp S, Zhang H, Zhao C, Xiao X, Chang M, Hirsch SA, Shepard PJ, Koo S, Murphy C, Glazer RI, Dean NM. Koller E, et al. Among authors: dean nm. Cancer Res. 2006 Feb 15;66(4):2059-66. doi: 10.1158/0008-5472.CAN-05-1531. Cancer Res. 2006. PMID: 16489005

4

Antisense oligonucleotides targeting human protein kinase C-alpha inhibit phorbol ester-induced reduction of bradykinin-evoked calcium mobilization in A549 cells.

Levesque L, Dean NM, Sasmor H, Crooke ST. Levesque L, et al. Among authors: dean nm. Mol Pharmacol. 1997 Feb;51(2):209-16. doi: 10.1124/mol.51.2.209. Mol Pharmacol. 1997. PMID: 9203625

5

Inhibition of expression of the multidrug resistance-associated P-glycoprotein of by phosphorothioate and 5' cholesterol-conjugated phosphorothioate antisense oligonucleotides.

Alahari SK, Dean NM, Fisher MH, Delong R, Manoharan M, Tivel KL, Juliano RL. Alahari SK, et al. Among authors: dean nm. Mol Pharmacol. 1996 Oct;50(4):808-19. Mol Pharmacol. 1996. PMID: 8863825

6

Inhibition of protein kinase C-alpha expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides.

Dean NM, McKay R. Dean NM, et al. Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11762-6. doi: 10.1073/pnas.91.24.11762. Proc Natl Acad Sci U S A. 1994. PMID: 7972137 Free PMC article.

7

Definition by specific antisense oligonucleotides of a role for protein kinase C alpha in expression of differentiation markers in normal and neoplastic mouse epidermal keratinocytes.

Lee YS, Dlugosz AA, McKay R, Dean NM, Yuspa SH. Lee YS, et al. Among authors: dean nm. Mol Carcinog. 1997 Jan;18(1):44-53. Mol Carcinog. 1997. PMID: 9022812

8

Inhibition of growth of human tumor cell lines in nude mice by an antisense of oligonucleotide inhibitor of protein kinase C-alpha expression.

Dean N, McKay R, Miraglia L, Howard R, Cooper S, Giddings J, Nicklin P, Meister L, Ziel R, Geiger T, Muller M, Fabbro D. Dean N, et al. Cancer Res. 1996 Aug 1;56(15):3499-507. Cancer Res. 1996. PMID: 8758918

9

Reduction of expression of the multidrug resistance protein (MRP) in human tumor cells by antisense phosphorothioate oligonucleotides.

Stewart AJ, Canitrot Y, Baracchini E, Dean NM, Deeley RG, Cole SP. Stewart AJ, et al. Among authors: dean nm. Biochem Pharmacol. 1996 Feb 23;51(4):461-9. doi: 10.1016/0006-2952(95)02220-1. Biochem Pharmacol. 1996. PMID: 8619891

10

Deletion of individual exons and induction of soluble murine interleukin-5 receptor-alpha chain expression through antisense oligonucleotide-mediated redirection of pre-mRNA splicing.

Karras JG, McKay RA, Dean NM, Monia BP. Karras JG, et al. Among authors: dean nm. Mol Pharmacol. 2000 Aug;58(2):380-7. doi: 10.1124/mol.58.2.380. Mol Pharmacol. 2000. PMID: 10908306

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters